| Revenue | — | — |
| EBITDA | SEK -28K | +51% |
| Net profit | SEK -1,2M | -481% |
| Total assets | SEK 2,4M | -33% |
| Equity | SEK 1,1M | -53% |
| Employees | 0 | — |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | — | — |
| Staff expenses | — | — | — | — | — |
| EBITDA | −122 | −128 | −73 | −56 | −28 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | −122 | −128 | −73 | −56 | −28 |
| Net financials | −380 | −439 | — | −147 | −1 155 |
| Profit before tax | −302 | −344 | −73 | −203 | −1 183 |
| Tax | −0 | −0 | −0 | — | — |
| Net profit | −302 | −344 | −73 | −203 | −1 183 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 138 | 3 778 | 3 756 | 3 562 | 2 369 |
| Equity | 2 869 | 2 477 | 2 454 | 2 250 | 1 068 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 1 269 | 1 302 | 1 302 | 1 312 | 1 302 |
| Total debt | 1 269 | 1 302 | 1 302 | 1 312 | 1 302 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
SJ | Audit | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
| Person | Role here | Other companies |
|---|---|---|
| Sten Johan Pharmanson | Audit | 0 companies |
| Kitty Leifsdotter Victor | Deputy Board Member | 0 companies |
| Per Fabian Victor | Chairman | 0 companies |
| Pål Hans Bo Holst Victor | Board of Directors | 0 companies |